Table 1 Clinical characteristics of patients and controls

Age (years)

25,63

7,67

24,44

5,69

0,567

Weight

60,43

15,37

66,17

16,08

0,099

BMI (k/m ² )

24,25

7,68

24,80

5,88

0,436

HCY μmol/ml.

10,90

3,60

12,37

4,05

0,073

MDA (nMol/ml)

6,47

3,63

5,59

2,55

0,396

NO (microMol/L)

8,73

3,04

9,54

4,16

0,595

SH (mMol/L)

6,96

6,07

10,92

7,76

0,172

TAFI

9,89

5,06

12,14

10,01

0,563

Fasting Glucose (mg/dl)

84,39

18,27

91,79

8,99

0,005

Fasting insulin (mIU/ml)

11,09

21,22

15,78

33,23

0,507

Homocysteine (μmol/L)

1,27

1,24

3,83

9,17

0,168

Estradiol (pg/ml)

51,65

58,40

35,13

26,82

0,052

DHEA-S (μg/dl)

272,93

131,36

217,19

115,69

0,035

17 -OHP (ng/ml)

1,10

1,05

1,85

1,04

0,002

Total-Testosterone (ng/ml)

0,92

1,30

0,96

1,85

0,905

Free-Testosterone (pg/ml)

1,76

0,83

3,28

2,12

0,001

Prolactin (pmol)

17,09

10,76

17,01

8,00

0,969

Total-cholesterol (mg/dl)

171,34

61,74

198,95

41,19

0,009

Triglycerides (mg/dl)

88,52

50,83

124,00

69,35

0,014

HDL-C (mg/dl)

59,37

16,39

57,06

15,39

0,514

LDL-C (mg/dl)

98,89

31,83

117,68

31,71

0,01

Fibrinogen (mg/dl)

295,85

102,07

373,83

110,84

0,004